DEB JORN
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
EyePoint Pharmaceuticals, Inc.
Filing Date
Source Excerpt
2018-05-11
Deb Jorn 75,000 *
Data sourced from SEC filings. Last updated: 2026-03-05